Skin biopsy rates and incidence of melanoma: population based ecological study
- PMID: 16081427
- PMCID: PMC1199022
- DOI: 10.1136/bmj.38516.649537.E0
Skin biopsy rates and incidence of melanoma: population based ecological study
Abstract
Objectives: To describe changes in skin biopsy rates and to determine their relation with changes in the incidence of melanoma.
Design: Population based ecological study.
Setting: Nine geographical areas of the United States.
Participants: Participants of the Surveillance Epidemiology and End Results (SEER) programme aged 65 and older.
Main outcome measures: For the period 1986 to 2001, annual skin biopsy rates for each surveillance area from Medicare claims and incidence rates for melanoma for the same population.
Results: Between 1986 and 2001 the average biopsy rate across the nine participating areas increased 2.5-fold among people aged 65 and older (2847 to 7222 per 100,000 population). Over the same period the average incidence of melanoma increased 2.4-fold (45 to 108 per 100,000 population). Assuming that the occurrence of true disease was constant, the extra number of melanoma cases that were diagnosed after carrying out 1000 additional biopsies was 12.6 (95% confidence interval 11.2 to 14.0). After controlling for a potential increase in the true occurrence of disease, 1000 additional biopsies were still associated with 6.9 (3.1 to 10.8) extra melanoma cases diagnosed. Stage specific analyses suggested that 1000 biopsies were associated with 4.4 (2.1 to 6.8) extra cases of in situ melanoma diagnosed and 2.3 (0.0 to 4.6) extra cases of local melanoma, but not with the incidence of advanced melanoma. Mortality from melanoma changed little during the period.
Conclusion: The incidence of melanoma is associated with biopsy rates. That the extra cases diagnosed were confined to early stage cancer while mortality remained stable suggests overdiagnosis-the increased incidence being largely the result of increased diagnostic scrutiny and not an increase in the incidence of disease.
Figures
Comment in
-
Melanoma incidence has risen in Europe.BMJ. 2005 Sep 24;331(7518):698. doi: 10.1136/bmj.331.7518.698. BMJ. 2005. PMID: 16179724 Free PMC article. No abstract available.
Similar articles
-
Skin biopsy utilization and melanoma incidence among Medicare beneficiaries.Br J Dermatol. 2017 Apr;176(4):949-954. doi: 10.1111/bjd.15077. Epub 2017 Mar 1. Br J Dermatol. 2017. PMID: 27639256 Free PMC article.
-
Delay of Surgery for Melanoma Among Medicare Beneficiaries.JAMA Dermatol. 2015 Jul;151(7):731-41. doi: 10.1001/jamadermatol.2015.119. JAMA Dermatol. 2015. PMID: 25853865
-
Economic burden of melanoma in the elderly population: population-based analysis of the Surveillance, Epidemiology, and End Results (SEER)--Medicare data.Arch Dermatol. 2010 Mar;146(3):249-56. doi: 10.1001/archdermatol.2009.389. Arch Dermatol. 2010. PMID: 20231494
-
Cancers with increasing incidence trends in the United States: 1999 through 2008.CA Cancer J Clin. 2012 Mar-Apr;62(2):118-28. doi: 10.3322/caac.20141. Epub 2012 Jan 4. CA Cancer J Clin. 2012. PMID: 22281605 Review.
-
Evidence concerning the accusation that melanoma is overdiagnosed.J Am Acad Dermatol. 2021 Oct;85(4):841-846. doi: 10.1016/j.jaad.2021.06.010. Epub 2021 Jun 8. J Am Acad Dermatol. 2021. PMID: 34116095 Review.
Cited by
-
The Burden of Thin Melanomas in Tuscany, Italy, 1985-2017: Age- and Sex-Specific Temporal Trends in Incidence and Mortality.Cancers (Basel). 2024 Jan 26;16(3):536. doi: 10.3390/cancers16030536. Cancers (Basel). 2024. PMID: 38339287 Free PMC article.
-
Multifractal analysis of cellular ATR-FTIR spectrum as a method for identifying and quantifying cancer cell metastatic levels.Sci Rep. 2023 Nov 2;13(1):18935. doi: 10.1038/s41598-023-46014-1. Sci Rep. 2023. PMID: 37919384 Free PMC article.
-
Current status of skin cancers with a focus on immunology and immunotherapy.Cancer Cell Int. 2023 Aug 21;23(1):174. doi: 10.1186/s12935-023-03012-7. Cancer Cell Int. 2023. PMID: 37605149 Free PMC article. Review.
-
Epidemiology of cutaneous melanoma in Blumenau, Santa Catarina state, Brazil from 1980 to 2019.An Bras Dermatol. 2023 Sep-Oct;98(5):611-619. doi: 10.1016/j.abd.2022.06.006. Epub 2023 Apr 28. An Bras Dermatol. 2023. PMID: 37121789 Free PMC article.
-
Revision of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis Classification Schema for Melanocytic Lesions: A Consensus Statement.JAMA Netw Open. 2023 Jan 3;6(1):e2250613. doi: 10.1001/jamanetworkopen.2022.50613. JAMA Netw Open. 2023. PMID: 36630138 Free PMC article.
References
-
- Swerlick RA, Chen S. The melanoma epidemic: more apparent than real? Mayo Clin Proc 1997;72: 559-64. - PubMed
-
- Florez A, Cruces M. Melanoma epidemic: true or false? Int J Dermatol 2004;43: 405-7. - PubMed
-
- Beddingfield FC. The melanoma epidemic: res ipsa loquitur. Oncologist 2003;8: 459-65. - PubMed
-
- Farmer ER, Gonin R, Hanna MP. Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists. Hum Pathol 1996;27: 528-31. - PubMed
-
- Corona R, Mele A, Amini M, De Rosa G, Coppola G, Piccardi P, et al. Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions. J Clin Oncol 1996;14: 1218-23. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical